Skip to main content
MED
NYSE Manufacturing

Medifast Amends Share Incentive Plan Proposal with Post-Exercise Holding Requirement Following ISS Feedback

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
8
Price
$10.875
Mkt Cap
$119.97M
52W Low
$9.22
52W High
$15.46
Market data snapshot near publication time

Summary

Medifast filed additional proxy materials, adopting a 12-month post-exercise holding requirement for executives and directors in response to an unfavorable recommendation from Institutional Shareholder Services regarding its proposed share incentive plan amendment.


Key Events

  • Proxy Supplement Filed

    Medifast issued additional proxy materials for its Annual Meeting of Stockholders to be held on May 19, 2026.

  • ISS Unfavorable Recommendation

    Institutional Shareholder Services (ISS) issued an unfavorable recommendation for Proposal 4, which seeks to increase shares for the 2012 Share Incentive Plan by 250,000.

  • New Post-Exercise Holding Policy Adopted

    In response to ISS's concerns, the Compensation Committee approved a 12-month post-exercise holding requirement for shares issued to executives and directors from stock options.

  • Board Reaffirms Support

    The Board of Directors reiterated its recommendation for stockholders to vote 'FOR' Proposal 4, as amended.


Analysis

This DEFA14A filing provides a material update to Medifast's definitive proxy statement, addressing a key concern raised by Institutional Shareholder Services (ISS) regarding the proposed amendment to the 2012 Share Incentive Plan. The adoption of a 12-month post-exercise holding requirement for shares issued to executives and directors from stock options aims to enhance corporate governance and better align management's interests with those of stockholders. This move is particularly important given the company's recent financial challenges, as noted in its last 10-K, and could influence institutional investor votes on the dilutive plan, which seeks to increase available shares by 250,000.

At the time of this filing, MED was trading at $10.88 on NYSE in the Manufacturing sector, with a market capitalization of approximately $120M. The 52-week trading range was $9.22 to $15.46. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MED - Latest Insights

MED
Jun 01, 2026, 9:03 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.19
Real-time Price: $11.94 info
Change: -$1.25 (-9%) info
Market Cap: $132.762M info
MED
Jun 01, 2026, 8:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.19
Real-time Price: $11.94 info
Change: -$1.25 (-9%) info
Market Cap: $132.762M info
MED
May 26, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.09
Real-time Price: $11.94 info
Change: -$1.15 (-9%) info
Market Cap: $132.762M info
MED
May 04, 2026, 4:51 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.94 info
Change: +$0.940 (+9%) info
Market Cap: $132.762M info
MED
May 04, 2026, 4:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.94 info
Change: +$0.940 (+9%) info
Market Cap: $132.762M info
MED
May 04, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.63
Real-time Price: $11.94 info
Change: +$1.31 (+12%) info
Market Cap: $132.762M info
MED
May 04, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.94 info
Change: +$0.940 (+9%) info
Market Cap: $132.762M info
MED
Apr 30, 2026, 9:24 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $10.88
Real-time Price: $11.94 info
Change: +$1.06 (+10%) info
Market Cap: $132.762M info
MED
Apr 06, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $10.52
Real-time Price: $11.94 info
Change: +$1.42 (+13%) info
Market Cap: $132.762M info
MED
Mar 27, 2026, 5:51 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $9.99
Real-time Price: $11.94 info
Change: +$1.95 (+19%) info
Market Cap: $132.762M info